Programmes of education in breast self-examination with specialist clinics for self-referral were introduced in two health districts around 1980. Combining the results from the two centres showed no reduction in mortality from breast cancer over the following 10 years but the mortality was low in one of the centres whilst in the other it was higher than in four geographically separate comparison centres in which there was similar careful monitoring of breast cancer incidence and mortality. Because this was not a randomised controlled trial and lacked a uniform treatment protocol, biases may be responsible for the differences observed, but it is also possible that BSE education with annual reinforcement contributed to the breast cancer mortality reduction seen in one district. The overall conclusion however is that the value of breast selfexamination remains unproven. There were differences between the centres in surgical and pathology practice, a major difference being in the proportion of breast cancer cases where nodal status was assessed, and the extent of such assessment. Consequently operable tumours are classified according to the maximum diameter reported by the pathologist rather than by nodal status. There was some variation between laboratories on whether measurements were made on fresh or fixed, or both fixed and sectioned material.
Interest in the UK Trial of Early Detection of Breast Cancer (TEDBC) has tended to focus on the effects of screening by mammography but the trial also includes two centres, Nottingham and Huddersfield, in which women were encouraged to practise breast self-examination (BSE). As an attempt to assess prospectively the effects of BSE encouragement on breast cancer mortality within a defined population it is unique.
It was found that, while the two screening centres presented a very similar pattern of breast cancer mortality, the two centres offering teaching in BSE were dissimilar. Details of the method of the trial (UK Trial of Early Detection of Breast Cancer Group, 1981) In contrast to benign biopsy the incidence of malignancy tended to rise with age at entry and was slightly lower in Huddersfield than in Nottingham, presenting a 7% increase relative to the combined comparison centres vs a 13% increase in Nottingham. Both BSE centres reported increased detection of tumours less than 21 mm, the rate in Huddersfield being slightly lower than that in Nottingham.
Neither BSE centre experienced much fall in the incidence of cancers over 20 mm or with fixation or distant metastasis ( Figure 1 ). Huddersfield, with a slightly raised rate in the early years which later 'crossed over' that of the comparison centres, follows the expected pattern for a successful early detection programme (Day et al., 1989 Mortality was consistently lower in attenders than in nonattenders but in Huddersfield both groups had low rates, whereas in Nottingham they both had high rates (Table IV) ,
Discussion
The first question to consider is whether the mortality difference between Huddersfield and Nottingham could be Year in trial The fact that Nottingham had a greater increase in breast cancer incidence than Huddersfield and the small size of I Cumulative incidence rates for tumours of size these increases relative to the 41-51% increase observed in .i or with fixation or distant metastasis.
the screening centres might be considered to rule out the possibility that the mortality reduction in Huddersfield is due ifferences in their BSE programmes. The programto the early detection programme. However it can be argued basically similar and it was Nottingham which that success may be critically dependent on the stage at the higher invitation response rate. However, which the faster growing cancers are picked up and that ould be influenced by the programme without attenbreast awareness and prompt self-referral by women who attendance may be a poor guide to whether women develop early signs of cancer may be important. A long lead BSE satisfactorily and whether, having discovered a time afforded to slow growing cancers, may raise detection sign, they refer themselves promptly for investigarates considerably, but be less critical. Artefacts of the study design must next be considered. In ow from an interview survey (Calnan et al., 1983) both centres publicity about the BSE programme could reach Nottingham 28% of women were practising BSE women before they were personally invited to attend, so that trily shortly before they were invited to participate, some cancers diagnosed early as a result of the programme a year later BSE practice among those who attended may have been excluded as 'pre-trial' cases. If such women had increased to 47% whereas in non-attenders it approached the Trial unit they were permitted to attend but at 33%. Over the same period practice increased were excluded from analysis. The ter detection against th lof-Differences in underlying breast cancer incidence could also lead to differences in mortality. The adjustment whereby expected deaths for each district were multiplied by the pretrial breast cancer SMRs was intended to counter bias due to differing underlying incidence rates but may fail to do so where boundary and demographic changes have occurred. It may also be relevant that the SMRs are based on all breast cancer deaths irrespective of the length of survival whereas the observed deaths in a study with limited follow up are biased towards exclusion of deaths after late recurrence; a centre where women traditionally referred themselves early would have a lower observed mortality in a study such as ours even though its SMR was 100%.
Trends in breast cancer mortality are shown in Figure 2 . These are for cancers which may have been diagnosed at any time in the past, whereas trial death rates refer to women who were apparently disease-free at entry. The trends confirm that some improvement has occurred in Huddersfield. The improvement was not seen in women over 74 but was as marked in women under 45 as in those who were in the trial age range. This suggests that if the BSE programme is responsible, the benefit may be from its general effect of increasing breast awareness rather than an effect restricted to those directly targeted.
During the TEDBC period the results of clinical trials of mastectomy vs breast conservation were beginning to influence management (Gazet et al., 1985) , and some of the centres were themselves running further trials. It is unlikely that differences in extent of surgery shown in Table II assumption that such therapy reduces mortality of cancers without local fixation or distant metastasis by about 25% we can estimate the extent to which equal use of these agents in all centres might have reduced differences between centres (Table V) (Locker et al., 1989) . They compared prognostic factors of cases detected after the BSE campaign began with those in a pre-trial series of cases notified by the local cancer registry and also used a case-control design to compare the BSE class attendance of women who died of breast cancer with that of age-matched controls. Ascertainment of cases was not, however, as thorough in the pre-trial period as during the trial and lead time and length biases also make interpretation difficult. Likewise the case-control method is prone to selection bias which has been found to exaggerate the estimate of benefit in studies of mammographic screening trials (Moss et al., 1992; Gulberg et al., 1991) . The casecontrol method may also have been biased by the exclusion from consideration of cancers detected in the first 3 months after invitation.
We conclude that the favourable mortality in Huddersfield may be partly due to the programme but it is also influenced by biases which cannot be corrected for. The difficulties experienced in trying to evaluate the BSE programmes naturally raise the question of the validity of inferences about the screening centres since they were compared with the same, geographically separate populations. The consistency of mortality reduction between the two screening centres (UK Trial of Early Detection of Breast Cancer Group, in press) and the similarity with results from elsewhere together with the conformity of the cancer incidence patterns to theoretical expectations in regard to prevalence/incidence ratios, size distribution at detection and incidence rates in the intervals between screens strongly suggest that women in the screening centres did benefit. The size of benefit cannot however be accurately estimated in view of the sources of bias which have been discussed. Unfortunately the only current BSE trials which might provide more conclusive evidence, are trials in Moscow, Len- ingrad and East Berlin (Koroltchouk, 1990) in which factories are randomised, and these trials are jeopardised by political upheavals. The suggestion that a BSE programme with annual, personal, postal reminders may be effective, especially in societies where late cancer presentation is common, could be further pursued. A trial based solely on postal BSE encouragement in Belfast (Turner et al., 1984) showed some impact on behaviour although it was too small and v' n short-lived to show an effect on breast cancer mortality. Perhaps a larger and more sustained randomised controlled trial of BSE encouragement, based solely on postal reminders, should be attempted in a situation where the cost of mammographic screening is prohibitive.
This work was funded by the Department of Health but does not necessarily represent the views of the Department.
